Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[A DNA medication pass for everyone?]

Nederlands tijdschrift voor geneeskunde - 19 Apr 2023

Vos Cornelis Niels F, De Wildt Saskia N, Kramers Cornelis Kees

Abstract excerpt

Pharmacogenetics holds the promise of personalized medicine, resulting in higher effectiveness and fewer adverse effects. Yet, the clinical benefit of a pre-emptive pharmacogenetic test has not been demonstrated rigorously. Recently an open-label real-world implementation study has been published, in which patients were randomized to either genotype-informed treatment (based on a 12-gene pharmacogenetic panel) or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to DNA
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Precision Medicine

Source

Identifiers

PMID: 37078568

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[A DNA medication pass for everyone?]PMID 37078568Read ↗

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.Semantic proximity Read ↗

Pharmacogenetics in Psychiatry: An Update on Clinical UsabilitySemantic proximity Read ↗

Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Semantic proximity Read ↗

[Assessment of the ethical consequences of genotype-based pharmacotherapy].Semantic proximity Read ↗

Exploring the impact of pharmacogenetics on personalized medicine: A systematic review.Semantic proximity Read ↗

Exploring the impact of pharmacogenetics on personalized medicine: A systematic review.Semantic proximity Read ↗

Outcomes and Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management - A Cohort Study in 135 PatientsSemantic proximity Read ↗

Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?Semantic proximity Read ↗

Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect.Semantic proximity Read ↗

[Pharmacogenetic testing: soon before every prescription?].Semantic proximity Read ↗

Real-world Clinical Effectiveness, Regulatory Transparency and Payer Coverage: Three Ingredients for Translating Pharmacogenomics into Clinical PracticeSemantic proximity Read ↗

[Ethics on genetic research (1). Pharmacogenetic studies].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.